Today Novartis Singapore broke ground on the expansion of its biopharmaceutical manufacturing facility in Singapore. The US$256 million investment will allow us to deploy digital and automation solutions and enhance manufacturing productivity, improve operational efficiency and upskill our workforce. The expanded site will focus on manufacturing therapeutic antibody drugs to deliver breakthrough treatments to patients globally. Thank you Mr Heng Swee Keat, Deputy Prime Minister and Coordinating Minister for Economic Policies, Cindy Koh from the Singapore Economic Development Board (EDB), Ambassador Frank Grütter from the Embassy of Switzerland in Singapore , Steffen Lang, Christoph Buerki, Ana Locatelli, SwissCham Singapore, European Chamber of Commerce, Singapore (EuroCham Singapore), EU-ASEAN Business Council, US-ASEAN Business Council, The American Chamber of Commerce in Singapore (AmCham Singapore) and all who joined us today to celebrate this milestone! Read more about our expansion here https://lnkd.in/gj4-Wve2
Congratulations to the Site. Glad to be part of this journey!
Congratulations 🎉 Glad to be part of this project as Energy Efficiency Opportunities Assessor along with Dr Lal Jayamaha. All the best Novartis team , keep going 🎉
Congratulations to all, Best wishes for a successful journey
Congratulations 👏👏
Fantastic news! Great to see the site growing! Congrats to the entire team!
Congratulations to all and best wishes.
Cheah Ling C
Congratulations
Driving net-zero transition | Novartis | KPMG | PWC | EY | ISB
5moAnother important milestone in our journey to reimagine medicine for our patients.